Financials Beijing Wandong Medical Technology Co.,Ltd.

Equities

600055

CNE000000PZ1

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
15.58 CNY +3.11% Intraday chart for Beijing Wandong Medical Technology Co.,Ltd. +7.89% -8.78%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4,694 5,581 5,423 12,759 13,738 12,008
Enterprise Value (EV) 1 4,002 4,850 4,267 11,646 10,419 8,585
P/E ratio 31 x 33 x 24.6 x 69.6 x 73.5 x 63.5 x
Yield 1.15% 0.48% 1.28% 0.42% 0.61% 0.76%
Capitalization / Revenue 4.92 x 5.68 x 4.79 x 11 x 12.3 x 9.71 x
EV / Revenue 4.19 x 4.94 x 3.77 x 10.1 x 9.29 x 6.94 x
EV / EBITDA 23.2 x 21 x 13.7 x 52.8 x 66.9 x 81.9 x
EV / FCF 184 x 10.9 x 13.1 x 100,061 x 138 x 123 x
FCF Yield 0.54% 9.14% 7.64% 0% 0.73% 0.81%
Price to Book 2.39 x 2.65 x 2.38 x 5.33 x 2.98 x 2.55 x
Nbr of stocks (in thousands) 540,816 540,816 535,878 535,878 703,061 703,061
Reference price 2 8.680 10.32 10.12 23.81 19.54 17.08
Announcement Date 19-04-26 20-04-28 21-04-28 22-04-22 23-04-18 24-03-22
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 954.5 982.4 1,132 1,156 1,121 1,237
EBITDA 1 172.1 231.2 311.5 220.6 155.6 104.8
EBIT 1 134.8 192.4 273.4 186.7 124.9 79.06
Operating Margin 14.13% 19.58% 24.15% 16.15% 11.14% 6.39%
Earnings before Tax (EBT) 1 173.1 191.2 263.8 207.2 192.4 213.3
Net income 1 153.3 168.9 220.7 183.2 175.4 188.5
Net margin 16.06% 17.19% 19.5% 15.84% 15.64% 15.25%
EPS 2 0.2800 0.3130 0.4120 0.3420 0.2660 0.2690
Free Cash Flow 1 21.74 443.1 326.1 0.1164 75.56 69.89
FCF margin 2.28% 45.1% 28.81% 0.01% 6.74% 5.65%
FCF Conversion (EBITDA) 12.63% 191.66% 104.69% 0.05% 48.55% 66.7%
FCF Conversion (Net income) 14.18% 262.36% 147.78% 0.06% 43.09% 37.07%
Dividend per Share 2 0.1000 0.0500 0.1300 0.1000 0.1200 0.1300
Announcement Date 19-04-26 20-04-28 21-04-28 22-04-22 23-04-18 24-03-22
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 693 731 1,156 1,113 3,319 3,424
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 21.7 443 326 0.12 75.6 69.9
ROE (net income / shareholders' equity) 7.61% 7.86% 9.57% 7.38% 4.77% 4%
ROA (Net income/ Total Assets) 3.54% 4.8% 6.3% 4.07% 1.92% 0.93%
Assets 1 4,332 3,515 3,504 4,503 9,140 20,336
Book Value Per Share 2 3.630 3.900 4.260 4.470 6.550 6.700
Cash Flow per Share 2 0.6500 0.9400 1.340 1.650 4.610 4.890
Capex 1 42.6 41.4 23.1 11.9 14 17.1
Capex / Sales 4.46% 4.22% 2.04% 1.02% 1.25% 1.38%
Announcement Date 19-04-26 20-04-28 21-04-28 22-04-22 23-04-18 24-03-22
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600055 Stock
  4. Financials Beijing Wandong Medical Technology Co.,Ltd.